Paricalcitol

Paricalcitol

Paricalcitol Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

1.1 Chronic Kidney Disease Stages 3 and 4

Paricalcitol capsules are indicated for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4.

1.2 Chronic Kidney Disease Stage 5

Paricalcitol Capsules are indicated for the prevention and treatment of secondary hyperparathyroidism associated with CKD Stage 5 in patients on hemodialysis (HD) or peritoneal dialysis (PD).

History

There is currently no drug history available for this drug.

Other Information

Paricalcitol, USP, the active ingredient in paricalcitol capsules, is a synthetically manufactured analog of calcitriol, the metabolically active form of vitamin D indicated for the prevention and treatment of secondary hyperparathyroidism in chronic kidney disease. Paricalcitol is available as soft gelatin capsules for oral administration containing 1 microgram, 2 micrograms or 4 micrograms of paricalcitol. Each capsule also contains the following inactive ingredients: ammonium hydroxide, butylated hydroxytoluene, ethanol, gelatin, glycerin, iron oxide black, propylene glycol, purified water, shellac glaze, soya lecithin, titanium dioxide, and triglycerides. Additionally, the 1 mcg tablet contains FD&C blue #1; the 2 mcg and 4 mcg tablets contain FD&C yellow #6 and iron oxide yellow.

Paricalcitol is a white to almost white powder. Paricalcitol is chemically designated as (1α,3β,7E, 22E)-19-nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol and has the following structural formula:

Paricalcitol structural formula

Paricalcitol Manufacturers


  • American Health Packaging
    Paricalcitol Capsule, Liquid Filled [American Health Packaging]
  • Hospira, Inc.
    Paricalcitol Injection, Solution [Hospira, Inc.]
  • Teva Pharmaceuticals Usa Inc
    Paricalcitol Capsule, Liquid Filled [Teva Pharmaceuticals Usa Inc]
  • Banner Pharmacaps
    Paricalcitol Capsule, Liquid Filled [Banner Pharmacaps]
  • Golden State Medical Supply, Inc.
    Paricalcitol Capsule, Liquid Filled [Golden State Medical Supply, Inc.]
  • Dr. Reddy’s Laboratories Limited
    Paricalcitol Capsule, Liquid Filled [Dr. Reddy’s Laboratories Limited]
  • Zydus Pharmaceuticals Usa Inc
    Paricalcitol Capsule, Liquid Filled [Zydus Pharmaceuticals Usa Inc]

Login To Your Free Account